Similarly, the growth of B16F10-OVA cancer was restrained by biNV-IL-15/OVA treatment instead of biNV-IL-15/HCP treatment (Fig. 6f, Supplementary Fig. 16b). This evidence concerns the gene IL15 and cancer.